Free Trial

Clover Health Investments (CLOV) to Release Quarterly Earnings on Thursday

Clover Health Investments logo with Medical background

Clover Health Investments (NASDAQ:CLOV - Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $346.92 million for the quarter. Parties interested in participating in the company's conference call can do so using this link.

Clover Health Investments Stock Down 5.0 %

Clover Health Investments stock traded down $0.22 during trading on Monday, reaching $4.18. The stock had a trading volume of 5,781,404 shares, compared to its average volume of 6,142,481. Clover Health Investments has a 52-week low of $0.61 and a 52-week high of $4.87. The business has a 50 day moving average price of $3.96 and a 200 day moving average price of $3.54. The stock has a market cap of $2.09 billion, a PE ratio of -20.90 and a beta of 1.98.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum started coverage on Clover Health Investments in a report on Tuesday, December 17th. They issued a "buy" rating and a $6.00 target price on the stock.

Read Our Latest Report on Clover Health Investments

Clover Health Investments Company Profile

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Featured Articles

Earnings History for Clover Health Investments (NASDAQ:CLOV)

Should You Invest $1,000 in Clover Health Investments Right Now?

Before you consider Clover Health Investments, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.

While Clover Health Investments currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines